4CPS-179 The wide review of polypharmacy in the frail older person

Abstract

screening process time, from 7.8 hours (range 4 to 11.6) in the control to 3.5 hours (range 1.8 to 5.2) in the active period, a statistically significant difference of 4.3 hours (95% CI 0.2 to 8.5, p=0.039). The transcribing error rate during the active period was 4%, lower than the 27% in the control period (c 2 (1)=36.46, p<0.001). Conclusion and relevance Involving OWPs in transcribing supportive medication reduced the IPChx delivery time and the occurrence of transcribing errors. Nonetheless, inconsistencies between current practice and hospital targets raised important issues that may imply that a further evaluation of the whole IPChx process is required. Consequently, further research is required to establish if additional interventions are required to improve waiting times for oncology patients.